Letter to the Editor
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Oncol. Sep 24, 2024; 15(9): 1251-1255
Published online Sep 24, 2024. doi: 10.5306/wjco.v15.i9.1251
Timing of antiviral therapy in patients with hepatitis B virus related hepatocellular carcinoma undergoing hepatectomy
Dong-Ling Wan, Li-Qi Sun
Dong-Ling Wan, Li-Qi Sun, Department of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai 200433, China
Li-Qi Sun, Department of Gastroenterology, 72th Group Army Hospital, Huzhou 313000, Zhejiang Province, China
Author contributions: Wan DL is the main author of the manuscript and has made substantial contributions to the reference acquisition and analysis, and manuscript preparation; Sun LQ is the guarantor of integrity of the entire manuscript final version approval; All authors read and approved the final manuscript.
Conflict-of-interest statement: All authors declare that they have no competing interests.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Li-Qi Sun, MD, Doctor, Department of Gastroenterology, Changhai Hospital, Naval Medical University, No. 168 Changhai Road, Yangpu District, Shanghai 200433, China. zjhzslqsmmu@foxmail.com
Received: April 23, 2024
Revised: August 8, 2024
Accepted: August 19, 2024
Published online: September 24, 2024
Processing time: 127 Days and 16.8 Hours
Core Tip

Core Tip: Hepatocellular carcinoma (HCC) is one of the most common and highly fatal malignancies worldwide and is usually associated with hepatitis B virus (HBV) infection. Hepatectomy is a widely accepted curative treatment for HCC, but the long-term survival rate is still unsatisfactory due to the high recurrence rate after resection. Preoperative or postoperative antiviral therapy plays an important role in improving the prognosis for HBV-related HCC patients who underwent hepatectomy. Therefore, we explored when antiviral therapy is more appropriate and whether perioperative rescue antiviral therapy can achieve the effect of preoperative long-term antiviral therapy in the paper.